Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus

NCT00315614 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped We did not achieve a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.

Conditions

Interventions

Sponsor

University of Miami

Collaborators